Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 8Stomach Neoplasms 3Rectal Neoplasms 3Neoplasms 3Colonic Neoplasms 3Carcinoma, Hepatocellular 3Prostatic Neoplasms 2Pancreatic cancer, adult 2Lung Neoplasms 2Recurrence 1Pancreatic carcinoma, familial 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Metabolic Syndrome 1Liver Cirrhosis 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Glioblastoma 1Fibrosis 1Fatigue 1Esophageal Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 271Fluorouracil 268Capecitabine 235Leucovorin 209Irinotecan 152Radiotherapy 139Bevacizumab 114Cetuximab 82Surgical Procedures, Operative 51Folfox protocol 49Neoadjuvant Therapy 45Drug Therapy 43Radiation 42Chemotherapy, Adjuvant 34Chemoradiotherapy 34Panitumumab 27Magnetic Resonance Spectroscopy 26XELOX 25Radiotherapy, Intensity-Modulated 23Biopsy 20Surveys and Questionnaires 18Laparoscopy 18Proctectomy 17Floxuridine 17Early Intervention, Educational 16Nivolumab 15Immunohistochemistry 15Gene Expression Profiling 15Gemcitabine 15pembrolizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Rectal Neoplasms × Hematologic Tests × Gastrointestinal × Clear all
NCT06730035 2024-12-12

PRediction of Outcomes and PERsonalized Radiotherapy by Biomarkers and Functional Imaging

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase NA Active not recruiting
30 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02288078 2014-11-13

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

Clinical Research Support Center Kyush

Phase 2 Unknown
74 enrolled
Gastrointestinal

Fatigue, Rectal Neoplasms

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Clinical Research Support Center Kyush

Phase 2 Unknown
110 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡